XML 80 R15.htm IDEA: XBRL DOCUMENT v3.19.3
Derivative Instruments
9 Months Ended
Sep. 30, 2019
Derivative Instruments and Hedging Activities Disclosure [Abstract]  
Derivative Instruments
Note 6. Derivative Instruments

The Company uses derivative instruments to manage a variety of risks, including risks related to fluctuations in foreign currency exchange rates and interest rates on debt instruments. We do not use derivative financial instruments for speculative purposes.

The notional amount of the Company's derivatives is summarized as follows (in millions):
 
As of
 
September 30,
2019
 
December 31,
2018
Designated derivatives:
 
 
 
Cash flow hedges
$
533.4

 
$
497.7

Interest rate swap contracts
300.0

 

Total designated derivatives
833.4

 
497.7

 
 
 
 
Non-designated derivatives
161.9

 
158.7

   Total
$
995.3

 
$
656.4



Designated Derivatives

The Company uses foreign currency forward contracts to hedge the Company's planned cost of revenues and operating expenses denominated in foreign currencies. These derivatives are designated as cash flow hedges. Execution of cash flow hedge derivatives typically occurs every month with maturities of eighteen months or less. As of September 30, 2019, an estimated $8.8 million of unrealized net loss within accumulated other comprehensive loss is expected to be reclassified into earnings within the next twelve months.

The Company recognized an unrealized loss of $12.4 million and $11.1 million in accumulated other comprehensive income for the effective portion of its derivative instruments for the three and nine months ended September 30, 2019, respectively; and an unrealized loss of $6.1 million and $8.6 million for the comparable periods in fiscal 2018, respectively. The Company reclassified a loss of $0.8 million and $1.5 million out of accumulated other comprehensive income to cost of revenues and operating expenses in the Condensed Consolidated Statements of Operations during the three and nine months ended September 30, 2019, respectively, and a loss of $3.1 million and a gain of $5.8 million for the comparable periods in fiscal 2018, respectively.

In September 2019, the Company entered into interest rate swaps with an aggregate notional amount of $300.0 million designated as fair value hedges of our fixed-rate 2041 Notes. These swaps convert the fixed interest rates of the notes to floating interest rates based on the London InterBank Offered Rate (LIBOR). Most of the interest rate swaps will expire within ten years or less. The Company recognizes the change in fair value of the derivative instrument, as well as the offsetting change in the fair value of the hedged item, in Other expense, net in the Condensed Consolidated Statements of Operations in the period of change. These derivatives are classified in the Condensed Consolidated Statements of Cash Flows in the same section as the underlying item.

See Note 5, Fair Value Measurements, for the fair values of the Company's derivative instruments in the Condensed Consolidated Balance Sheets.

Non-Designated Derivatives

The Company also uses foreign currency forward contracts to mitigate variability in gains and losses generated from the remeasurement of certain monetary assets and liabilities denominated in foreign currencies. These foreign exchange forward contracts typically have maturities of approximately one to four months. The outstanding non-designated derivative instruments are carried at fair value. Changes in the fair value of these derivatives recorded in other expense, net within the Condensed Consolidated Statements of Operations were not material during the three and nine months ended September 30, 2019 and September 30, 2018.